Besides, Luo et al. (2021) found that CDKN2A was highly expressed in HCC and associated with a decreased OS via facilitating the proliferation of cancer cells and inhibiting apoptosis. The gene discussed is CDKN2A; the disease is hepatocellular carcinoma.